{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:40:40Z","timestamp":1775929240396,"version":"3.50.1"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1984,1,1]],"date-time":"1984-01-01T00:00:00Z","timestamp":441763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can Anaesth Soc J"],"published-print":{"date-parts":[[1984,1]]},"DOI":"10.1007\/bf03011484","type":"journal-article","created":{"date-parts":[[2008,12,14]],"date-time":"2008-12-14T08:52:03Z","timestamp":1229244723000},"page":"61-75","source":"Crossref","is-referenced-by-count":87,"title":["Dantrolene"],"prefix":"10.1007","volume":"31","author":[{"given":"Beverley A.","family":"Britt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03011484_CR1","unstructured":"Norwich-Eaton Pharmaceuticals (Division of Norwich-Eaton, Ltd.). 1979. Dantrium Intravenous (Dantrolene Sodium Intravenous). Product Monograph."},{"key":"BF03011484_CR2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/jm00317a011","volume":"10","author":"HR Snyder","year":"1967","unstructured":"Snyder HR Jr,Davis CS, Bickerton RK, Halliday RP. l-[(5-Arylfurfurylidine)]amino hydantoins. A new class of muscle relaxants. J Med Chem 1967; 10: 807\u201310.","journal-title":"J Med Chem"},{"key":"BF03011484_CR3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00000542-198101000-00012","volume":"54","author":"C Lee","year":"1981","unstructured":"Lee C, Durant NN, Au E, Kau RL. Reversal of dantrolene sodium-induced depression of skeletal muscle in the cat. Anesthesiology 1981; 54: 61\u20135.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jps.2600690319","volume":"69","author":"KO Ellis","year":"1980","unstructured":"Ellis KO, White RL Jr,Wright GC, Wessels FL. Synthesis and skeletal muscle relaxant activity of quaternary ammonium salts of dantrolene and clodanolene. J Pharm Sci 1980; 69: 327\u201331.","journal-title":"J Pharm Sci"},{"key":"BF03011484_CR5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jps.2600620619","volume":"62","author":"KO Eitis","year":"1973","unstructured":"Eitis KO, Castellion AW, Honkomp LJ, Wessels FL, Carpenter JF, Halliday RP. Dantrolene, a direct acting skeletal muscle relaxant. J Pharm Sci 1973; 62: 948\u201351.","journal-title":"J Pharm Sci"},{"key":"BF03011484_CR6","first-page":"153","volume":"64C","author":"CA Cotton","year":"1979","unstructured":"Cotton CA, Colton JS, The action of dantrolene sodium on the lobster neuromuscular junction. Comp Biochem Physiol 1979; 64C: 153\u20136.","journal-title":"Comp Biochem Physiol"},{"key":"BF03011484_CR7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0014-2999(80)90414-8","volume":"68","author":"NN Durant","year":"1980","unstructured":"Durant NN, Lee C, Katz RL. The action of dantrolene on transmitter mobilization at the rat neuro-muscular junction. Eur J Pharmacol 1980; 68: 403\u20138.","journal-title":"Eur J Pharmacol"},{"key":"BF03011484_CR8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1113\/jphysiol.1981.sp013591","volume":"311","author":"C Karup","year":"1981","unstructured":"Karup C. The effect of dantrolene on the enhancement and diminution of tension evoked by staircase and by tetanus in rat muscle. J Physiol 1981; 311: 389\u2013400.","journal-title":"J Physiol"},{"key":"BF03011484_CR9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1113\/jphysiol.1981.sp013851","volume":"318","author":"GC Leslie","year":"1981","unstructured":"Leslie GC, Pan NJ. Effect of dantrolene sodium on twitch contractions of individual motor units in the rat. J Physiol 1981; 318: 24.","journal-title":"J Physiol"},{"key":"BF03011484_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1440-1681.1974.tb00532.x","volume":"1","author":"MW Nott","year":"1974","unstructured":"Nott MW, Bowman WC. Actions of dantrolene sodium on contractions of the tibialis anterior and soleus muscles of cats under chloralose anaesthesia. Clin Exp Pharmacol Physiol 1974; 1: 113\u201322.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF03011484_CR11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00501011","volume":"274","author":"KO Ellis","year":"1972","unstructured":"Ellis KO, Bryant SH. Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 1972; 274: 107\u20139.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"BF03011484_CR12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1113\/jphysiol.1977.sp011731","volume":"265","author":"JE Desmedt","year":"1977","unstructured":"Desmedt JE, Hainaut K, Inhibition of the intra-cellular release of calcium by dantrolene in barnacle giant muscle fibres. J Physiol 1977; 265: 565\u201385.","journal-title":"J Physiol"},{"key":"BF03011484_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00505069","volume":"275","author":"KO Ellis","year":"1972","unstructured":"Ellis KO, Carpenter JF. Studies on the mechanism of action of dantrolene sodium: A skeletal muscle relaxant, Naunyn-Schmiedeberg\u2019s Arch Pharmacol 1972; 275: 83\u201394.","journal-title":"Arch Pharmacol"},{"key":"BF03011484_CR14","first-page":"772","volume":"32","author":"JW Putney","year":"1973","unstructured":"Putney JW Jr,Bianchi CP. Effect of dantrolene in E-C coupling in skeletal muscle. FEBS 1973, 32; 772.","journal-title":"FEBS"},{"key":"BF03011484_CR15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.1977.tb06986.x","volume":"59","author":"R Moulds","year":"1977","unstructured":"Moulds R. Comparison of the effect of sodium thiocyanate and dantrolene sodium on a mammalian isolated skeletal muscle. Br J Pharmacol 1977; 59: 129\u201333.","journal-title":"Br J Pharmacol"},{"key":"BF03011484_CR16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/bja\/51.8.753","volume":"51","author":"PJ Haisall","year":"1979","unstructured":"Haisall PJ, Ellis FR. A screening test for the malignant hyperpyrexia phenotype using suxa-methonium-induced contracture of muscle treated with caffeine, and its inhibition by dantrolene. Br JAnaesth 1979; 51: 753\u20135.","journal-title":"Br JAnaesth"},{"key":"BF03011484_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00000542-198009000-00004","volume":"53","author":"AS Fairhurst","year":"1980","unstructured":"Fairhurst AS, Hamamoto V, Macri J. Modification of ryanodinc toxicity by dantrolene and halo-thane in a model of malignant hyperthermia. Anesthesiology 1980; 53: 199\u2013204,","journal-title":"Anesthesiology"},{"key":"BF03011484_CR18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/bja\/52.4.377","volume":"52","author":"F Okumura","year":"1980","unstructured":"Okumura F, Crocker BD, Denborough MA. Site of the muscle cell abnormality in swine susceptible to malignant hyperpyrexia. Br J Anaesth 1980; 52: 377\u201383.","journal-title":"Br J Anaesth"},{"key":"BF03011484_CR19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/254364a0","volume":"254","author":"L Brocklehurst","year":"1975","unstructured":"Brocklehurst L. Dantrolene sodium and \u2018skinned\u2019 muscle fibres. Nature 1975; 254: 364.","journal-title":"Nature"},{"key":"BF03011484_CR20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1139\/y81-057","volume":"59","author":"T Oba","year":"1981","unstructured":"Oba T. Influence of temperature and external Ca2+ concentration upon dantrolene action on excitation-contraction coupling in frog skeletal muscle. Can J Physiol Pharmacol 1981; 59: 358\u201363.","journal-title":"Can J Physiol Pharmacol"},{"key":"BF03011484_CR21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/mus.880020610","volume":"2","author":"EM Gallant","year":"1979","unstructured":"Gallant EM, Godt RD, Gronert GA. Role of plasma membrane defect of skeletal muscle in malignant hyperthermia. Muscle and Nerve 1979; 2: 491\u20134.","journal-title":"Muscle and Nerve"},{"key":"BF03011484_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-2999(80)90163-6","volume":"61","author":"AD Korczyn","year":"1980","unstructured":"Korczyn AD, Shavit S, Schlosberg I. The chick as a model for malignant hyperpyrexia. Eur J Pharmacol 1980; 61: 187\u20139.","journal-title":"Eur J Pharmacol"},{"key":"BF03011484_CR23","first-page":"670","volume":"30","author":"KO Ellis","year":"1971","unstructured":"Ellis KO, Carpenter JF. The effect of dantrolene sodium (F440) on skeletal muscle. Fed Proc 1971; 30: 670.","journal-title":"Fed Proc"},{"key":"BF03011484_CR24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00000542-198002000-00004","volume":"52","author":"EH Flewelkn","year":"1980","unstructured":"Flewelkn EH, Nelson TE, Bee DE. Effect of dantrolene on neuromuscular block by d-tubocurarine and subsequent antagonism by neostigmine in the rabbit. Anesthesiology 1980; 52: 126\u201330.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3565(25)30836-0","volume":"201","author":"KG Morgan","year":"1977","unstructured":"Morgan KG, Bryant SH. The mechanism of action of dantrolene sodium. J Pharmacol Exp Therap 1977; 201: 138\u201347.","journal-title":"J Pharmacol Exp Therap"},{"key":"BF03011484_CR26","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0006-2952(79)90286-7","volume":"28","author":"JE Desmedt","year":"1979","unstructured":"Desmedt JE, Hainaut K, Dantrolene and A23187 ionophore: specific action on calcium channels revealed by the aequorin method. Biochem Pharmacol 1979; 28: 957\u201364.","journal-title":"Biochem Pharmacol"},{"key":"BF03011484_CR27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/BF03006162","volume":"26","author":"TE Nelson","year":"1979","unstructured":"Nelson TE, Flewellen EH. Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility? Can Anaesth Soc J 1979; 26: 484\u20138.","journal-title":"Can Anaesth Soc J"},{"key":"BF03011484_CR28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00000542-197902000-00008","volume":"50","author":"TE Nelson","year":"1979","unstructured":"Nelson TE, Flewellen EH. Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia. Anesthesiology 1979; 50: 118.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF03006842","volume":"27","author":"EH Flewellen","year":"1980","unstructured":"Flewellen EH, Nelson TE, Bee DE. Porcine malignant hyperthermia - failure of dantrolene dose response to diagnose susceptibility (halothane effect). Can Anaesth Soc J 1980; 27: 16\u201321.","journal-title":"Can Anaesth Soc J"},{"key":"BF03011484_CR30","first-page":"331","volume":"37","author":"EH Flewellen","year":"1978","unstructured":"Flewellen EH, Nelson TE. A comparison of dantrolene and procainamide on in vivo muscle twitch of malignant hyperthermia susceptible pigs. FEBS 1978; 37: 331.","journal-title":"FEBS"},{"key":"BF03011484_CR31","first-page":"509","volume-title":"Second International Symposium on Malignant Hyperthermia","author":"IL Anderson","year":"1978","unstructured":"Anderson IL, Lipicky RJ, Jones EW. Dantrolene sodium in porcine malignant hyperthermia: studies on isolated muscle strips. In: Second International Symposium on Malignant Hyperthermia (eds,Aldrete, J.A. andBritt, B.A.), Grune & Stratton, New York, p. 509\u201334 (1978)."},{"key":"BF03011484_CR32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.1981.tb09147.x","volume":"72","author":"GC Leslie","year":"1981","unstructured":"Leslie GC, Part NJ. The action of dantrolene sodium on rat fast and slow muscle in vivo. Br J Pharmac 1981; 72: 665\u201372.","journal-title":"Br J Pharmac"},{"key":"BF03011484_CR33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000542-197601000-00013","volume":"44","author":"IL Anderson","year":"1976","unstructured":"Anderson IL, Jones EW. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle. Anesthesiology 1976; 44: 57\u201361.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR34","first-page":"417","volume":"91","author":"IL Anderson","year":"1980","unstructured":"Anderson IL, Rawstron RE, Dunlop DJ. Screening for malignant hyperthermia susceptibility. NZ Med J 1980; 91: 417\u20139.","journal-title":"NZ Med J"},{"key":"BF03011484_CR35","first-page":"23","volume-title":"Second International Symposium on Malignant Hyperthermia","author":"TE Nelson","year":"1978","unstructured":"Nelson TE. Excitation-contraction coupling: a common etiologic pathway for malignant hyperthermia susceptible muscle. In: Second International Symposium on Malignant Hyperthermia (eds.Aldrete, J.A. andBritt, B.A. Grune & Stratton, New York, p. 23\u201336 (1978)."},{"key":"BF03011484_CR36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF03007443","volume":"27","author":"H Rosenberg","year":"1980","unstructured":"Rosenberg H. Dantrolene and caffeine contracture test (letter to the editor). Can Anaesth Soc J 1980; 27: 303\u20134.","journal-title":"Can Anaesth Soc J"},{"key":"BF03011484_CR37","first-page":"304","volume":"27","author":"W Lambert","year":"1980","unstructured":"Lambert W. Dantrolene and caffeine contracture test (letter to the editor). Can Anaesth Soc J 1980; 27: 304.","journal-title":"Can Anaesth Soc J"},{"key":"BF03011484_CR38","unstructured":"Britt BA. Unpublished data. (1981)."},{"key":"BF03011484_CR39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0014-5793(80)80908-2","volume":"117","author":"C Sengupta","year":"1980","unstructured":"Sengupta C, Meyer UA, Carafoli E. Binding of dantrolene sodium to muscle intracellular membranes, FEBS 1980; 117: 37\u20138.","journal-title":"FEBS"},{"key":"BF03011484_CR40","first-page":"772","volume":"32","author":"JL Butterfield","year":"1973","unstructured":"Butterfield JL, Ellis KO. Effects of dantrolene sodium, a skeletal muscle relaxant, on the contractility of cardiac and smooth muscle. Fed Proc 1973; 32: 772.","journal-title":"Fed Proc"},{"key":"BF03011484_CR41","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/jps.2600650925","volume":"65","author":"KO Ellis","year":"1976","unstructured":"Ellis KO, Wessels FL, Carpenter JF. Effects of intravenous dantrolene sodium on respiratory and cardiovascular functions. J Pharmaceut Sci 1976; 65: 1359\u201363.","journal-title":"J Pharmaceut Sci"},{"key":"BF03011484_CR42","first-page":"118","volume":"224","author":"KO Ellis","year":"1976","unstructured":"Ellis KO, Butterfield JL, Wessels FL, Carpenter JF. A comparison of skeletal, cardiac, and smooth muscle actions of dantrolene sodium - a skeletal muscle relaxant. Arch Int Pharmacodyn Ther 1976; 224: 118\u201332.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BF03011484_CR43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3181\/00379727-160-40384","volume":"160","author":"F Gollan","year":"1979","unstructured":"Gollan F, McDermott J. Effect of the skeletal muscle relaxant dantrolene sodium on the isolated, perfused heart (40384). Proc Soc Exp Biol Med 1979; 160: 42\u20135.","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF03011484_CR44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-2999(79)90197-3","volume":"55","author":"WC Bowman","year":"1979","unstructured":"Bowman WC, Houston J, Khan HH, Rodger IW. Effects of dantrolene sodium on respiratory and other muscles and on respiratory parameters in the anaesthetised cat. Eur J Pharmacol 1979; 55: 293\u2013303.","journal-title":"Eur J Pharmacol"},{"key":"BF03011484_CR45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2044.1975.tb00862.x","volume":"30","author":"GA Gronert","year":"1975","unstructured":"Gronert GA. Malignant hyperthermia. Anesthesiology 1980; 53: 395-423. 46 Ellis RH, Simpson P, Tatham P, Leighton, M, Williams J. The cardiovascular effects of dantrolene sodium in dogs. Anaesthesia 1975; 30: 318\u201322.","journal-title":"Anaesthesia"},{"key":"BF03011484_CR46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1139\/y78-080","volume":"56","author":"AI Ally","year":"1978","unstructured":"Ally AI, Horrobin DF, Manku MS et al. Dantro-lene blocks intracellular calcium release in smooth muscle: competitive antagonism of thromboxane A2. Can J Physiol Pharmacol 1978; 56: 520\u20133.","journal-title":"Can J Physiol Pharmacol"},{"key":"BF03011484_CR47","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0024-3205(80)90252-0","volume":"26","author":"LE Bailey","year":"1980","unstructured":"Bailey LE, Shibata S, Seriguchi DG, Dresei PE. Inhibition of the positive inotropic effect of antho-pleurin-A (AP-A) by dantrolene. Life Sciences 1980; 26: 1061\u20138.","journal-title":"Life Sciences"},{"key":"BF03011484_CR48","first-page":"13","volume":"28","author":"A Plizga","year":"1980","unstructured":"Plizga A, Holl JE. Myocardial depression associated with effective refractory period prolongation after pentobarbital and procainamide but not after dantrolene.Res Comm Chem Pathol Pharmacol 1980; 28: 13\u201326.","journal-title":"es Comm Chem Pathol Pharmacol"},{"key":"BF03011484_CR49","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0022-2828(80)90056-5","volume":"12","author":"J Hatae","year":"1980","unstructured":"Hatae J, Ohba M, Kawata M. Effects of dantrolene sodium on the excitation-contraction coupling of the mammalian and amphibian cardiac muscle. J Mol Cell Cardiol 1980; 12: 857\u201367.","journal-title":"J Mol Cell Cardiol"},{"key":"BF03011484_CR50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3565(25)32912-5","volume":"220","author":"JJ Salata","year":"1982","unstructured":"Salata JJ, Jalife J, Effects of dantrolene sodium on the electrophysiological properties of cacine cardiac Purkinje fibers. J Pharmacol Exp Ther 1982; 220: 157\u201366.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF03011484_CR51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0090-4295(80)90095-3","volume":"16","author":"JD Harris","year":"1980","unstructured":"Harris JD, Benson GS, Effect of dantrolene sodium on canine bladder contractility. Urology 1980; 16: 229\u201331,","journal-title":"Urology"},{"key":"BF03011484_CR52","first-page":"188","volume":"17","author":"IM Khalaf","year":"1979","unstructured":"Khalaf IM, Foley G, Elhilali MM. The effect of dantrium on the canine urethral pressure profile. Investigative Urology 1979; 17: 188\u201390.","journal-title":"Investigative Urology"},{"key":"BF03011484_CR53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-5347(17)55305-7","volume":"124","author":"RH Hackler","year":"1980","unstructured":"Hackler RH, Broecker BH, Klein FA, Brady SM. A clinical experience with dantrolene sodium for external urinary sphincter hypertonicity in spinal cord injured patients. J Urol 1980; 124: 78\u201381.","journal-title":"J Urol"},{"key":"BF03011484_CR54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(81)90162-X","volume":"70","author":"M Mahmoudian","year":"1981","unstructured":"Mahmoudian M, Dehpour AR, Mofakham S. Effect of dantrolene sodium on the contractility of rabbit jejunum in vitro. Eur J Pharmacol 1981; 70: 287\u201392.","journal-title":"Eur J Pharmacol"},{"key":"BF03011484_CR55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/bja\/47.1.62","volume":"47","author":"GG Harrison","year":"1975","unstructured":"Harrison GG. Control of the malignant hyper-pyrexic syndrome in MHS swine by dantrolene sodium. Br J Anaesth 1975; 47: 62\u20135.","journal-title":"Br J Anaesth"},{"key":"BF03011484_CR56","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2044.1977.tb09985.x","volume":"32","author":"GM Hall","year":"1977","unstructured":"Hall GM, Lucke JN, Lister D. Treatment of porcine malignant hyperthermia. The successful use of dantrolene in the Pietrain pig. Anaesthesia 1977; 32: 472.","journal-title":"Anaesthesia"},{"key":"BF03011484_CR57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/bja\/52.2.165","volume":"52","author":"GM. Lucke JN Hall","year":"1980","unstructured":"Hall GM. Lucke JN, Lister D. Malignant hyperthermia \u2014 pearls out of swine? Br J Anaesth 1980; 52: 165\u201371.","journal-title":"Br J Anaesth"},{"key":"BF03011484_CR58","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00000542-197606000-00005","volume":"44","author":"GA Gronert","year":"1976","unstructured":"Gronert GA, Milde JH, Theye RA. Dantrolene in porcine malignant hyperthermia. Anesthesiology 1976; 44: 488\u201395.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/bmj.2.5806.145","volume":"2","author":"LW Hall","year":"1972","unstructured":"Hall LW, Trim CM, Woolfe N, Further studies on porcine malignant hyperthermia. Br Med J 1972; 2: 145.","journal-title":"Br Med J"},{"key":"BF03011484_CR60","unstructured":"Ellis KO. Personal communication. Norwich Eaton Pharmaceuticals, Norwich, N.Y. (1981)."},{"key":"BF03011484_CR61","first-page":"21","volume":"15","author":"H Fukuchi","year":"1979","unstructured":"Fukuchi H, Kuwata N, Seki Y, Morio M. Preparation and stability of parenteral solution of 0.4W\/V% dantrolene sodium. Hiroshima J Anesthesia 1979; 15:21\u20134.","journal-title":"Hiroshima J Anesthesia"},{"issue":"Suppl","key":"BF03011484_CR62","first-page":"119","volume":"13","author":"H Fukuchi","year":"1977","unstructured":"Fukuchi H, Morio M. Preparation of dantrolene sodium for intravenous use. Hiroshima J Anesthesia 1977; 13 (Suppl):1199.","journal-title":"Hiroshima J Anesthesia"},{"issue":"Suppl.","key":"BF03011484_CR63","first-page":"101","volume":"15","author":"F Tomonaga","year":"1979","unstructured":"Tomonaga F, Kobayashi T, Yago K, et al. Pharmaceutical studies of dantrolene sodium. Hiroshima J Anesthesia 1979; 15 (Suppl.):101\u201388.","journal-title":"Hiroshima J Anesthesia"},{"key":"BF03011484_CR64","first-page":"535","volume-title":"Second International Symposium on Malignant Hyperthermia","author":"GA Gronert","year":"1978","unstructured":"Gronert GA, Mansfield E, Theye RA. Rapidly soluble dantrolene for intravenous use. In: Second International Symposium on Malignant Hyperthermia (eds.Aldrete, J.A. andBritt, B.A.), Grune & Stratton, N.Y., p, 535\u20136 (1978),"},{"key":"BF03011484_CR65","first-page":"27","volume":"9","author":"H Drechsler","year":"1979","unstructured":"Drechsler H. Zur therapie der malignen hyperthermie. Anaesthesist 1981; 30: 257-8. 67 Editorial Dantrolene sodium approved for malignant hyperthermia. FDA Drug Bulletin 1979; 9: 27.","journal-title":"FDA Drug Bulletin"},{"key":"BF03011484_CR66","doi-asserted-by":"crossref","unstructured":"Ryan JF. Treatment of acute hyperthermia crises. In: International Anesthesiology Clinics: Malignant Hyperthermia. (ed. Britt, B.A.). 1979; 17: 153\u201368.","DOI":"10.1097\/00004311-197901740-00010"},{"key":"BF03011484_CR67","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00000542-197911000-00016","volume":"51","author":"A Mathieu","year":"1979","unstructured":"Mathieu A, Bogosian AJ, Ryan JF, Crone, RK, Crocker D. Recrudescence after survival of an initial episode of malignant hyperthermia. Anesthesiology 1979; 51: 454\u20135.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1213\/00000539-197901000-00011","volume":"58","author":"DK Faust","year":"1979","unstructured":"Faust DK, Gergis SD, Sokoll MD. Management of suspected malignant hyperpyrexia in an infant, Anesth Analg 1979; 58: 33\u20135.","journal-title":"Anesth Analg"},{"key":"BF03011484_CR69","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF03006294","volume":"26","author":"CM Friesen","year":"1979","unstructured":"Friesen CM, Brodsky JB, Dillingham MG. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report. Can Anaesth Soc J 1979; 26: 319\u201321.","journal-title":"Can Anaesth Soc J"},{"key":"BF03011484_CR70","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/bja\/51.9.899","volume":"51","author":"F Liebenschutz","year":"1979","unstructured":"Liebenschutz F, Mai C, Pickerodt VWA, Increased carbon dioxide production in two patients with malignant hyperpyrexia and its control by dantrolene. Br J Anaesth 1979; 51: 899\u2013903.","journal-title":"Br J Anaesth"},{"key":"BF03011484_CR71","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2044.1980.tb04998.x","volume":"35","author":"SEF Jones","year":"1980","unstructured":"Jones SEF, Thomas CH. Malignant hyperthermia in a patient with an ankylosed jaw. Anaesthesia 1980; 35: 987\u201390.","journal-title":"Anaesthesia"},{"key":"BF03011484_CR72","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00003246-198009000-00013","volume":"8","author":"B Hoff","year":"1980","unstructured":"Hoff B, Taylor C, Kruel J. Dantrolene therapy for malignant hyperthermia (letter to the editor). Crit Care Med 1980; 8: 699\u2013700.","journal-title":"Crit Care Med"},{"key":"BF03011484_CR73","first-page":"909","volume":"60","author":"GG Harrison","year":"1981","unstructured":"Harrison GG. Dantrolene sodium in the treatment of MH: a case report. S Afr Med J 1981; 60: 909\u201310.","journal-title":"S Afr Med J"},{"key":"BF03011484_CR74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004311-197917040-00004","volume":"17","author":"MA Denborough","year":"1979","unstructured":"Denborough MA. Etiology and pathophysiology of malignant hyperthermia. In: International Anesthe-siology Clinics: Malignant Hyperthermia. (ed. Britt, B.A). 1979; 17: 11\u201326.","journal-title":"International Anesthe-siology Clinics: Malignant Hyperthermia"},{"key":"BF03011484_CR75","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/978-3-642-68569-9_17","volume-title":"Handbook of Experimental Pharmacology, Pyretics and Antipyretics","author":"BA Britt","year":"1982","unstructured":"Britt, BA. Malignant hyperthermia \u2014 a review. In, Handbook of Experimental Pharmacology, Pyretics and Antipyretics (ed.Milton, A.S.), Springer-Verlag, Heidelberg. 1982; p. 547\u2013615."},{"key":"BF03011484_CR76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0039-6257(81)90074-6","volume":"25","author":"LA Sedwick","year":"1981","unstructured":"Sedwick LA, Romano PE. Malignant hyperthermia. Considerations for the ophthalmologist. Surv Ophthalmol 1981; 25: 378\u201382.","journal-title":"Surv Ophthalmol"},{"key":"BF03011484_CR77","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1288\/00005537-198106000-00009","volume":"81","author":"JA Schvaneveldt","year":"1981","unstructured":"Schvaneveldt JA, Stankiewicz JA. Malignant hyper-pyrexia: an update for the otolaryngologist. The Laryngoscope 1981; 81: 918\u201326.","journal-title":"The Laryngoscope"},{"key":"BF03011484_CR78","first-page":"507","volume":"29","author":"B Landauer","year":"1980","unstructured":"Landauer B, Zur Behandlung der malignen Hyperthermie mit Dantrolen. Der Anaesthesist 1980; 29: 507\u20138.","journal-title":"Der Anaesthesist"},{"key":"BF03011484_CR79","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00006534-198203000-00029","volume":"69","author":"LE Dohlman","year":"1982","unstructured":"Dohlman LE. Malignant hyperthermia: a consideration for plastic surgeons. Plastic and Reconstructive Surgery 1982; 69: 547\u201351.","journal-title":"Plastic and Reconstructive Surgery"},{"key":"BF03011484_CR80","first-page":"30","volume":"151","author":"S Hopkins","year":"1980","unstructured":"Hopkins S. Dantrolene sodium. Nursing Mirror 1980; 151: 30.","journal-title":"Nursing Mirror"},{"key":"BF03011484_CR81","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/bja\/49.4.315","volume":"49","author":"GG Harrison","year":"1977","unstructured":"Harrison GG. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine. Br J Anaesth 1977, 49: 315\u20137.","journal-title":"Br J Anaesth"},{"key":"BF03011484_CR82","first-page":"499","volume-title":"Second International Symposium on Malignant Hyperthermia","author":"DD Kerr","year":"1978","unstructured":"Kerr DD, Wingard DW, Gatz EE. Prevention of porcine malignant hyperthermia by oral dantrolene. In: Second International Symposium on Malignant Hyperthermia (eds.Aldrete, J.A. andBritt, B.A.), Grune & Stratton, New York, 1978; 499\u2013507."},{"key":"BF03011484_CR83","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000542-198004000-00003","volume":"52","author":"EH Flewellen","year":"1980","unstructured":"Flewellen EH, Nelson TE. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis. Anesthesiology 1980; 52: 303\u20138.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR84","first-page":"1001","volume":"51","author":"EH Flewelten","year":"1978","unstructured":"Flewelten EH, Nelson TE. Porcine malignant hyperthermia: a method to produce dantrolene prophylaxis and therapeusis. Anesthesiology 1978; 51: 1001.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR85","first-page":"438","volume":"38","author":"DM Gallagher","year":"1980","unstructured":"Gallagher DM, Hyer RL. Effective use of dantrolene in a patient susceptible to malignant hyperthermia. J Oral Surgery 1980; 38: 438\u201340.","journal-title":"J Oral Surgery"},{"key":"BF03011484_CR86","first-page":"493","volume":"88","author":"CW Free","year":"1978","unstructured":"Free CW, Jaimon MPC. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report. NZ Med J 1978; 88: 493\u20134.","journal-title":"NZ Med J"},{"key":"BF03011484_CR87","first-page":"719","volume":"37","author":"SL Bronstein","year":"1979","unstructured":"Bronstein SL, Ryan DE, Solomons CC, Mahowald MC.Dantrolene sodium in the management of patients at risk from malignant hyperthermia. J Oral Surgery 1979; 37: 719\u201324.","journal-title":"J Oral Surgery"},{"key":"BF03011484_CR88","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00000542-198101000-00014","volume":"54","author":"DC Fitzgibbons","year":"1981","unstructured":"Fitzgibbons DC. Malignant hyperthermia following preoperative oral administration of dantrolene. Anesthesiology 1981; 54: 73\u20135.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR89","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2106\/00004623-197961070-00015","volume":"61-A","author":"OM Jardon","year":"1979","unstructured":"Jardon OM, Wingard DW, Barak AJ, Connolly JF. Malignant hyperthermia. A potentially fatal syndrome in orthopaedic patients. J Bone and Joint Surgery 1979; 61-A: 1064\u201370.","journal-title":"J Bone and Joint Surgery"},{"key":"BF03011484_CR90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004311-197917040-00009","volume":"17","author":"JES Relton","year":"1979","unstructured":"Relton JES. Anesthesia for elective surgery in patients susceptible to malignant hyperthermia. In: International Anesthesiology Clinics: Malignant Hyperthermia. (ed. Britt, B.A.). 1979; 17: 141\u201351,","journal-title":"International Anesthesiology Clinics: Malignant Hyperthermia"},{"key":"BF03011484_CR91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000542-198101000-00001","volume":"54","author":"GA Gronert","year":"1981","unstructured":"Gronert GA. Puzzles in malignant hyperthermia. Anesthesiology 1981; 54: 1\u20132.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR92","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/bja\/52.9.847","volume":"52","author":"GM Hall","year":"1980","unstructured":"Hall GM. Editorial. Dantrolene and the treatment of malignant hyperthermia. Br J Anaesth 1980; 52: 847\u20139.","journal-title":"Br J Anaesth"},{"key":"BF03011484_CR93","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00000542-197902000-00016","volume":"50","author":"SK Pandit","year":"1979","unstructured":"Pandit SK, Kothary SP, Cohen PJ. Orally administered dantrolene for prophylaxis of malignant hyperthermia. Anesthesiology 1979; 50: 156\u20138.","journal-title":"Anesthesiology"},{"key":"BF03011484_CR94","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF03006842","volume":"27","author":"EH Flwellen","year":"1980","unstructured":"Flwellen EH, Nelson TE, Bee DE. Porcine malignant hyperthermia - failure of dantrolene dose response to diagnose susceptibility (halothane effect). Can Anaesth Soc J 1980; 27: 16\u201321.","journal-title":"Can Anaesth Soc J"},{"key":"BF03011484_CR95","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1213\/00000539-198005000-00011","volume":"59","author":"GA Gronert","year":"1980","unstructured":"Gronert GA, Thompson RL, Onofrio BM, Human malignant hyperthermia; awake episodes and correction by dantrolene. Anesth Analg 1980; 59: 377\u20138.","journal-title":"Anesth Analg"},{"key":"BF03011484_CR96","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/00007611-197107000-00011","volume":"64","author":"SB Chyatte","year":"1971","unstructured":"Chyatte SB, Birdsong JH. The use of dantrolene sodium in disorders of the central nervous system. Southern Med J 1971; 64: 830\u20134.","journal-title":"Southern Med J"},{"key":"BF03011484_CR97","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/WNL.23.12.1313","volume":"23","author":"AJ Gelenberg","year":"1973","unstructured":"Gelenberg AJ, Poskanzer DC. The effect of dantrolene sodium on spasticity in multiple sclerosis. Neurology 1973; 23: 1313\u20135.","journal-title":"Neurology"},{"key":"BF03011484_CR98","first-page":"365","volume":"54","author":"SB Chyatte","year":"1973","unstructured":"Chyatte SB, Birdsong JH, Roberson DL, Dantrolene sodium in athetoid cerebral palsy. Arch Physical Med Rehab 1973; 54: 365\u20138.","journal-title":"Arch Physical Med Rehab"},{"key":"BF03011484_CR99","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00007611-197102000-00011","volume":"64","author":"SB Chyatte","year":"1971","unstructured":"Chyatte SB, Birdsong JH, Bergman BA. The effects of dantrolene sodium on spasticity and motor performance in hemiplegia. Southern Med J 1971; 64: 180\u20135.","journal-title":"Southern Med J"},{"key":"BF03011484_CR100","first-page":"18","volume":"52","author":"N Mayer","year":"1973","unstructured":"Mayer N,Mecomber SA, Herman R. Treatment of spasticity with dantrolene sodium. Am J Physical Med 1973; 52: 18\u201329.","journal-title":"Am J Physical Med"},{"key":"BF03011484_CR101","first-page":"60","volume":"54","author":"JV Basmajian","year":"1973","unstructured":"Basmajian JV, Super GA. Dantrolene sodium in the treatment of spasticity. Arch Physical Med Rehab 1973; 54: 60\u20135.","journal-title":"Arch Physical Med Rehab"},{"key":"BF03011484_CR102","first-page":"311","volume":"54","author":"SB Chyatte","year":"1973","unstructured":"Chyatte SB, Basmajian JV, Dantrolene sodium: long-term effects in severe spasticity. Arch Physical Med Rehab 1973; 54; 311\u20135.","journal-title":"Arch Physical Med Rehab"},{"key":"BF03011484_CR103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/gut.20.1.33","volume":"20","author":"SP Wilkinson","year":"1979","unstructured":"Wilkinson SP, Portmann B.Williams R. Hepatitis from dantrolene sodium. Gut 1979; 20: 33\u20136.","journal-title":"Gut"},{"key":"BF03011484_CR104","first-page":"1233","volume":"78","author":"GE Molnar","year":"1978","unstructured":"Molnar GE, Evangelista LA, Kathirithamby R. Dantrolene sodium in spasticity. Long-term administration in children. New York State J Med 1978; 78: 1233\u20137,","journal-title":"New York State J Med"},{"key":"BF03011484_CR105","first-page":"151","volume":"93","author":"LJ Fating","year":"1980","unstructured":"Fating LJ, Petusevsky ML, Snider GL. Nitro-furantoin and dantrolene; liver and lung. Ann Int Med 1980; 93: 151.","journal-title":"Ann Int Med"},{"key":"BF03011484_CR106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-0404.1979.tb02941.x","volume":"59","author":"J Mai","year":"1979","unstructured":"Mai J, Pedersen E, Mode of action of dantrolene sodium in spasticity. Acta Neurol Scandinav 1979; 59: 309\u201316.","journal-title":"Acta Neurol Scandinav"},{"key":"BF03011484_CR107","first-page":"123","volume":"221","author":"R Weiser","year":"1978","unstructured":"Weiser R, Terenty T, Hudgson P, Weightman D. Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease. The Practitioner 1978; 221: 123\u20137.","journal-title":"The Practitioner"},{"key":"BF03011484_CR108","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/WNL.29.12.1631","volume":"29","author":"H Feit","year":"1979","unstructured":"Feit H. A form of chorea that responds to dantrolene sodium. Neurology 1979; 29: 1631\u20132.","journal-title":"Neurology"},{"key":"BF03011484_CR109","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0014-4886(78)90286-8","volume":"62","author":"A Eberstein","year":"1978","unstructured":"Eberstein A, Goodgold J. Relief of myotonia by dantrolene in experimental myotonia. Exper Neurol 1978; 62: 804\u20139.","journal-title":"Exper Neurol"},{"key":"BF03011484_CR110","unstructured":"Glass A, Hannah A. A comparison of dantrolene sodium and diazepam in the treatment of spasticity. Report prepared from study being completed for publication. Kaiser Foundation Hospital, Terra Linda, California."},{"key":"BF03011484_CR111","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1469-8749.1980.tb03742.x","volume":"22","author":"RL Joynt","year":"1980","unstructured":"Joynt RL, Leonard, JA Jr. Dantrolene sodium suspension in treatment of spastic cerebral palsy. Develop Med Child Neurol 1980; 22: 755\u201367,","journal-title":"Develop Med Child Neurol"},{"key":"BF03011484_CR112","first-page":"296","volume":"51","author":"R Herman","year":"1972","unstructured":"Herman R, Mayer N, Mecomber SA. Clinical pharmaco-physiology of dantrolene sodium. Am J Physical Med 1972; 51: 296\u2013311.","journal-title":"Am J Physical Med"},{"key":"BF03011484_CR113","first-page":"401","volume":"22","author":"M Chipman","year":"1972","unstructured":"Chipman M, Kaul S. The efficacy of dantrolene sodium in the treatment of spasticity. Neurology 1972; 22: 401.","journal-title":"Neurology"},{"key":"BF03011484_CR114","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/jnnp.44.4.334","volume":"44","author":"WJ Meyler","year":"1981","unstructured":"Meyler WJ, Bakker H, Kok JJ, Agoston S, Wesseling H. The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration. J Neurol Neurosurg Psychiat 1981; 44: 334\u20139,","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"BF03011484_CR115","first-page":"420","volume":"5","author":"AG Nogen","year":"1979","unstructured":"Nogen AG. Effect of dantrolene sodium on the incidence of seizures in children with spasticity.Child\u2019s Brain 1979; 5: 420\u20135.","journal-title":"hild\u2019s Brain"},{"key":"BF03011484_CR116","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2044.1979.tb06270.x","volume":"34","author":"CB Collier","year":"1979","unstructured":"Collier CB. Dantrolene and suxamethonium. The effect of pre-operative dantrolene on the action of suxamethonium. Anaesthesia 1979; 34: 152\u20138.","journal-title":"Anaesthesia"},{"key":"BF03011484_CR117","first-page":"338","volume":"30","author":"J Platz","year":"1981","unstructured":"Platz J, Braun J, Stallenberger R. The inhibitory effect of dantrolene on the rise of serum-creatinekinase activity after combined use of halothane and suxamethonium in man. Anaesthesist 1981; 30: 338\u201342.","journal-title":"Anaesthesist"},{"key":"BF03011484_CR118","first-page":"475","volume":"93","author":"JM Hackl","year":"1981","unstructured":"Hackl JM, Engl J, Hofstadter F etal. Possible malignant hyperthermia as reaction to an overdose of myotonolytic, antidepressive and sedative drugs. Wien Klin Wochenschrift 1981; 93: 475\u20139,","journal-title":"Wien Klin Wochenschrift"},{"key":"BF03011484_CR119","first-page":"3572","volume":"10","author":"JL Delacour","year":"1981","unstructured":"Delacour JL, Daoudal P, Chapoutot JL, Rocq B. Traitement du syndrome malin des neuroleptiques par le dantrolene. La Nouvelle Presse Medicale 1981;10:3572\u20133.","journal-title":"La Nouvelle Presse Medicale"},{"key":"BF03011484_CR120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.1981.03320010023020","volume":"246","author":"JS Lydiatt","year":"1981","unstructured":"Lydiatt JS, Hill GE. Treatment of heat stroke with dantrolene. Letter to the Editor. JAMA 1981; 246:41\u20132.","journal-title":"JAMA"},{"key":"BF03011484_CR121","unstructured":"American Hospital Formulary Service, Published by the American Society of Hospital Pharmacists, Bethesda, Md. 20814."},{"key":"BF03011484_CR122","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-2044.1980.tb05007.x","volume":"35","author":"S Agoston","year":"1980","unstructured":"Agoston S. Dantrolene and suxamethonium. Letter to the editor. Anaesthesia 1980; 35: 1012\u20133.","journal-title":"Anaesthesia"},{"key":"BF03011484_CR123","first-page":"336","volume":"80","author":"M Cornette","year":"1980","unstructured":"Cornette M, Gillard C, Borll-Hermans G. H\u00e9patite toxique mortelle associ\u00e9e a l\u2019usage du dantrolene. Acta neurol belg 1980; 80: 336\u201347.","journal-title":"Acta neurol belg"},{"key":"BF03011484_CR124","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0041-008X(78)90252-1","volume":"44","author":"CO Abernathy","year":"1978","unstructured":"Abernathy CO, Utili R, Zimmerman HJ, Ezekiel M. The effects of dantrolene sodium on excretory function in the isolated perfused rat liver. Toxicol Appl Pharmacol 1978; 44: 441\u201352.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BF03011484_CR125","first-page":"507","volume":"27","author":"S Roy","year":"1980","unstructured":"Roy S, Francis KT, Born CK, Hamrick ME. Interaction of dantrolene with the hepatic mixed function oxidase system. Res Comm Chem Pathol Pharmacol 1980; 27: 507\u201320.","journal-title":"Res Comm Chem Pathol Pharmacol"},{"key":"BF03011484_CR126","first-page":"69","volume":"23","author":"KT Francis","year":"1979","unstructured":"Francis KT, Hamrick ME. Dantrolene inhibition of the hepatic mixed function oxidase system. Res Comm Chem Pathol Pharmacol 1979; 23: 69\u201380.","journal-title":"Res Comm Chem Pathol Pharmacol"},{"key":"BF03011484_CR127","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1001\/jama.1979.03300250028024","volume":"242","author":"ML Petusevsky","year":"1979","unstructured":"Petusevsky ML, Faling LJ, Rocklin RE, et al. Pleuropericardial reaction to treatment with dantrolene. JAMA 1979; 242: 2772\u20134.","journal-title":"JAMA"},{"key":"BF03011484_CR128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/pgmj.56.654.261","volume":"56","author":"HH Wan","year":"1980","unstructured":"Wan HH, Tucker JS. Dantrotene and lympho-cytic lymphoma. Postgrad Med J 1980; 56: 261\u20132.","journal-title":"Postgrad Med J"},{"key":"BF03011484_CR129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2133.1981.tb15319.x","volume":"104","author":"AC Pembroke","year":"1981","unstructured":"Pembroke AC, Saxena SR, KatariaM, Zilkha KD. Acne induced by dantrolene. Br J Dermatology 1981; 104: 465\u20138.","journal-title":"Br J Dermatology"},{"key":"BF03011484_CR130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00000542-198106000-00024","volume":"54","author":"JW Chapin","year":"1981","unstructured":"Chapin JW, Lou CG, Wingard DW. Asystole after intravenous dantrolene sodium in pigs. (Letter to the Editor) Anesthesiology 1981; 54: 527\u20138.","journal-title":"(Letter to the Editor) Anesthesiology"},{"key":"BF03011484_CR131","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0021-9673(00)80682-2","volume":"179","author":"LP Hackett","year":"1979","unstructured":"Hackett LP, Dusci LJ. Determination of dantrolene sodium in human plasma using high-performance liquid chromatography. J Chromatog-raphy 1979; 179: 222\u20134.","journal-title":"J Chromatog-raphy"},{"key":"BF03011484_CR132","first-page":"333","volume":"174","author":"RD.Conklin JD Hollifield","year":"1963","unstructured":"Hollifield RD.Conklin JD. A spectrophotofluorometric procedure for the determination of dantrolene in blood and urine. Arch Int Pharmacodyn 1963; 174:333\u201341.","journal-title":"Arch Int Pharmacodyn"},{"key":"BF03011484_CR133","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jps.2600620219","volume":"62","author":"RD.Conklin JD Hollifield","year":"1973","unstructured":"Hollifield RD.Conklin JD. Determination of dantrolene in biological specimens containing drug-related metabolites. J Pharm Sci 1973; 62; 271\u20134.","journal-title":"J Pharm Sci"},{"key":"BF03011484_CR134","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00507042","volume":"301","author":"KO Ellis","year":"1978","unstructured":"Ellis KO, Wesseis FL, Muscle relaxant properties of the identified metabolites of dantrolene. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 1978; 301: 237\u201340,","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"BF03011484_CR135","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jps.2600580818","volume":"58","author":"PL Cox","year":"1969","unstructured":"Cox PL, Heotis JP, Polin D, Rose GM. Quantitative determination of dantroiene sodium and its metabolites by differential pulse polarography, J Pharmaceutical Sci 1969; 58: 987\u20139.","journal-title":"J Pharmaceutical Sci"},{"key":"BF03011484_CR136","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jps.2600620219","volume":"62","author":"RD Hollifield","year":"1973","unstructured":"Hollifield RD, Conklin JD. Determination of dantrolene in biological specimens containing drug-related metabolites. J Pharmaceutical Sci 1973; 62: 271\u20134.","journal-title":"J Pharmaceutical Sci"}],"container-title":["Canadian Anaesthetists\u2019 Society Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03011484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03011484\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03011484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:09:29Z","timestamp":1738818569000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03011484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,1]]},"references-count":136,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1984,1]]}},"alternative-id":["BF03011484"],"URL":"https:\/\/doi.org\/10.1007\/bf03011484","relation":{},"ISSN":["0008-2856","1496-8975"],"issn-type":[{"value":"0008-2856","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,1]]}}}